We next measured circulating syndecan-1 in Cohort 2—women attending the Manchester Antenatal Vascular Service (MAViS clinic, in the United Kingdom, Table 2) who have underlying vascular disease (such as chronic hypertension or pre-existing diabetes). The gene discussed is SDC1; the disease is diabetes mellitus.